Nanomedicine Market Revenue 2025 to 2034
Nanomedicine Market Revenue 2025 to 2034
The nanomedicine market size is anticipated to grow from USD 265.88 billion in 2025 to USD 632.09 billion by 2034, with a compound annual growth rate (CAGR) of 10.1% during the forecast period from 2025 to 2034. The growing research and development activities and advancements in technology boost the market.
Report ID: 10146
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 241.49 Bn
Forecast Year,
USD USD 632.09 Bn
CAGR, 2025 -
10.1%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Nanomedicine Market Size Analysis
Nanomedicine Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Therapeutics | 84.52 | 93.16 | 102.69 | 113.19 | 124.77 | 137.52 | 151.59 | 167.09 | 184.17 | 203.00 | 223.76 |
| In-vitro Diagnostics | 36.22 | 39.86 | 43.85 | 48.25 | 53.09 | 58.41 | 64.26 | 70.71 | 77.80 | 85.60 | 94.18 |
| Drug Delivery | 60.37 | 66.52 | 73.30 | 80.77 | 89.00 | 98.06 | 108.05 | 119.06 | 131.19 | 144.56 | 159.28 |
| In-vivo Imaging | 36.22 | 39.83 | 43.79 | 48.15 | 52.94 | 58.21 | 64.01 | 70.38 | 77.38 | 85.08 | 93.55 |
| Implants | 24.15 | 26.51 | 29.10 | 31.94 | 35.06 | 38.48 | 42.24 | 46.37 | 50.89 | 55.86 | 61.31 |
Nanomedicine Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Oncology | 96.60 | 106.43 | 117.27 | 129.21 | 142.37 | 156.86 | 172.84 | 190.43 | 209.82 | 231.19 | 254.73 |
| Infectious Diseases | 48.30 | 53.20 | 58.61 | 64.56 | 71.11 | 78.33 | 86.29 | 95.05 | 104.70 | 115.34 | 127.05 |
| Clinical Cardiology | 36.22 | 39.86 | 43.85 | 48.25 | 53.09 | 58.41 | 64.26 | 70.71 | 77.80 | 85.60 | 94.18 |
| Orthopedics | 36.22 | 39.88 | 43.91 | 48.35 | 53.23 | 58.60 | 64.52 | 71.04 | 78.21 | 86.11 | 94.81 |
| Others | 24.15 | 26.51 | 29.10 | 31.94 | 35.06 | 38.48 | 42.24 | 46.37 | 50.89 | 55.86 | 61.31 |
Nanomedicine Market Size By Molecule Type 2024 to 2034 (USD )
| Molecule Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nanoparticles | 120.75 | 133.02 | 146.54 | 161.44 | 177.85 | 195.93 | 215.85 | 237.79 | 261.97 | 288.60 | 317.94 |
| Nanoshells | 48.30 | 53.15 | 58.49 | 64.36 | 70.83 | 77.94 | 85.77 | 94.39 | 103.87 | 114.30 | 125.78 |
| Nanotubes | 36.22 | 39.91 | 43.97 | 48.44 | 53.37 | 58.80 | 64.78 | 71.37 | 78.63 | 86.63 | 95.44 |
| Nanodevices | 36.22 | 39.80 | 43.73 | 48.06 | 52.80 | 58.02 | 63.75 | 70.05 | 76.96 | 84.56 | 92.92 |
Nanomedicine Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 94.18 | 103.83 | 114.46 | 126.18 | 139.10 | 153.35 | 169.05 | 186.36 | 205.44 | 226.48 | 249.67 |
| Europe | 65.20 | 71.71 | 78.86 | 86.73 | 95.38 | 104.90 | 115.37 | 126.88 | 139.54 | 153.46 | 168.77 |
| Asia-Pacific | 53.13 | 58.60 | 64.64 | 71.29 | 78.64 | 86.73 | 95.67 | 105.52 | 116.38 | 128.37 | 141.59 |
| Latin America | 16.90 | 18.56 | 20.37 | 22.37 | 24.56 | 26.96 | 29.59 | 32.49 | 35.67 | 39.15 | 42.98 |
| Middle East & Africa | 12.07 | 13.19 | 14.40 | 15.73 | 17.17 | 18.75 | 20.48 | 22.35 | 24.40 | 26.64 | 29.08 |
Nanomedicine Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
